Hyperprolactinemia and pregnancy: the basic achievements and unresolved problems
- Authors: Dzeranova LK1, Bykanova NS1, Pigarova EA1
- Affiliations:
- Endocrinology Research Centre, Moscow, Russia
- Issue: No 1 (2011)
- Pages: 16-21
- Section: Articles
- URL: https://endojournals.ru/repr/article/view/8560
- DOI: https://doi.org/10.14341/brh2011116-21
- Cite item
Abstract
From the sociopolitical and economic points of view the child-bearing is very actual problem for Russia. Demographers believe that our population can decrease twice in 25-30 years, because of medical factors partly.Every fifth family in Russia is infertility now. Female infertility is caused by hyperprolactinemia in 25-40 % of all cases. Rate of hyperprolactinemia at the infertile men reaches 30 %. However hyperprolactinemia is the cause of infertility which can be successfully cured now.
Курсив
Жирный
Обычный нижний верхний
Курсив
Жирный
Обычный нижний верхний
L K Dzeranova
Endocrinology Research Centre, Moscow, Russia
Author for correspondence.
Email: metabol@endocrincentr.ru
N S Bykanova
Endocrinology Research Centre, Moscow, Russia
Email: metabol@endocrincentr.ru
E A Pigarova
Endocrinology Research Centre, Moscow, Russia
Email: kpigarova@gmail.com
- Марова Е И Вакс В В Дзеранова Л К Гиперпролактинемия у женщин и мужчин Пособие для врачей М Pharmacia Upjohn 2000
- Дедов И И Мельниченко Г А Романцова Т И Синдром гиперпролактинемии М Тверь Триада, 2004
- Романцова Т И Особенности клинической симптоматики диагностики и лечения синдрома гиперпролактинемии у женщин Дисс д ра мед наук М. 2001
- Дзеранова Л К Синдром гиперпролактинемии у женщин и мужчин клиника диагностика лечение Дисс д ра мед наук М 2007.
- GillamMP MolitchME LombardiG Colao A Advances in the treatment of prolactinomas Endocr Rev 2006 27: 485 534
- Casanueva FF, Molitch ME, Schlechte JA et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas Clin Endocrin 2006 65: 265 273.
- Webster J, Piscitelli G, Polli A et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea N Engl J Med 1994 331: 904 909.
- Swearingen B, Biller BMK. Diagnosis and Management of Pituitary Disorders Humana Press 2008
- Casanueva FF Molitch ME Schlechte JA et al Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas Clin Endocrin 2006 65: 265 273
- Central Brain Tumor Registry of the United States (CTBRUS). Statistical Report. Primary brain tumors in the US 1997 2001 http://www.cbtrus.org/. Accessed April 8, 2005.
- Goluboff LG, Ezrin C Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis J Clin Endocrin Metab 1969 29: 1533 1538.
- Scheithauer BW, Sano T, Kovacs KT et al. The pituitary gland in pregnancy. A clinicopathologic and immunohistochemical study of 69 Cases Mayo Clin Proc 1990 65: 461 474.
- Rigg LA, Lein A, Yen SSC Pattern of increase in circulating prolactin levels during human gestation Am J Obstet Gyn 1977 129: 454 456.
- Gonzalez JG, Elizondo G, Saldivar D et al. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging Am J Med 1988 85: 217 220.
- Elster AD, Sanders TG, Vines FS et al. Size and shape of the pituitary gland during pregnancy and post partum: Measurement with MR imaging Radiology 1991 181: 531 535.
- Ricci E, Parazzini F, Motta T et al. Pregnancy outcome after cabergoline treatment in early weeks of gestation Reproduct Toxicol 2002 16:791 793
- Ono M, Miki N, Amano K et al. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas J Clin Endocrin Metab 2010 95: 2672 2679
- Molitch ME Pituitary disorders during pregnancy Endocrin Metabol Clin NorthAm2006 35 99 116.
- Kupersmith MJ, Rosenberg C, Kleinberg D. Visual loss in pregnant women with pituitary adenomas. Ann Internal Med 1994 121: 473 477.
- Molitch ME. Pregnancy and the hyperprolactinemic woman New Engl J Med 1985 312 1364 1370.
- Molitch ME Management of prolactinomas during pregnancy J Reprod Med 1999 44(12): 1121 1126
- Bronstein MD, Salgado LR, Musolino NR. Medical management of pituitary adenomas: The special case of the pregnant woman Pituitary 2002 5: 99 107.
- Moore WT, Eastman RC. Diagnostic Endocrinology. Acromegaly prolactin and gonadotropin secreting ademomas hypopituitaris Philadelphia, Decker 1996
- Cohen-Kerem R, Railton C, Orfen D et al. Pregnancy outcome following non-obstetric surgical intervention Am J Surg 2005 190 467 473.
- Lebbe M, Hubinont C, Bernard P, Maiter D.Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women Clin Endocrin (Oxf) 2010 73(2):236-42
- Davis JR, Farrell WE, Clayton RN. Pituitary tumours Reproduction 2001 121(3): 363-371.
- Jeffcoate WJ, Pound N, Sturrock ND et al. Long-term follow-up of patients with hyperprolactinaemia Clin Endocrin 1996 45 299 303.
- 28.Divers WA, Yen SSC Prolactin-producing microadenomas in pregnancy Obstet Gyn 1983 62: 425 429.
- Krupp P Monka C. Bromocriptine in pregnancy: safety aspects KlinischeWochenschrift 1987 65 823 827.
- Krupp P, Monka C, Richter K. The safety aspects of infertility treatments Program of the Second World Congress of Gynecology and Obstetrics, Rio de Janeiro, October, 1988.
- Robert E, Musatti L, Piscitelli G еt al. Pregnancy outcome after treatment with the ergot derivative, cabergoline Reprod Toxicol 1996 10: 333 337
- Colao A, Abs R, Gonzalez Ba rcena Dеt al. Pregnancy outcomes following cabergoline treatment: extended results from a 12- year observational study Clin Endocrin (Oxf) 2008 68(1): 66 71
- StalldeckerG Mallea-Gil MS GuitelmanMet al. Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature Pituitary 2010 13(4): 345-350.
- Nybo Andersen AM, Wohlfahrt J, Christens P et al. Maternal age fetal loss: population based register linkage study BMJ2000 320: 1708 1712
- Окороков А Н Гиперпролактинемический синдром Диагностика болезней внутренних органов М Мед лит 2001.
- Abech DD Moratelli HB Leite SC Oliveira MC. Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women Gyn Endocrin 2005 21(4): 223-236.
- Banerjee A, Wynne K, Tan T et al. High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy Clin Endocrin (Oxf) 2009 70(5): 812 813.
- Morange I, Barlier A, Pellegrini I et al. Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy Eur J Endocrin 1996 135: 413 420.
- Molitch ME. Prolactinomas and pregnancy Clin Endocrin 2010 73 147 148
Views
Abstract - 659
PDF (Russian) - 607
Cited-By
